Rationale for bipolar androgen therapy (BAT) for metastatic prostate cancer

Cell Cycle. 2017 Sep 17;16(18):1639-1640. doi: 10.1080/15384101.2017.1360645. Epub 2017 Aug 18.

Authors

John T Isaacs¹, W Nathaniel Brennen¹, Samuel R Denmeade¹

Affiliation

¹ a The Prostate Cancer Program, The Department of Oncology at the Sidney Kimmel Comprehensive Cancer Center and Brady Urological Institute, The Department of Urology , The Johns Hopkins School of Medicine , Baltimore , MD , USA.

No abstract available

Publication types

News
Comment

MeSH terms

Androgen Antagonists*
Androgens*
Humans
Male
Prostatic Neoplasms* / drug therapy

Substances

Androgen Antagonists
Androgens

Grants and funding

R01 CA184012/CA/NCI NIH HHS/United States